Literature DB >> 25891332

Impact of post prostate biopsy hemorrhage on multiparametric magnetic resonance imaging.

Ali-Reza Sharif-Afshar1, Tom Feng, Steven Koopman, Christopher Nguyen, Quanlin Li, Eugene Shkolyar, Rola Saouaf, Hyung L Kim.   

Abstract

INTRODUCTION: Hemorrhage induced by prostate biopsy can interfere with the interpretation of prostate magnetic resonance imaging (MRI).
MATERIALS AND METHODS: We reviewed 101 patients who had prostate multiparametric MRI (MP-MRI) and radical prostatectomy.
RESULTS: On MRI obtained within 4 weeks following the biopsy, hemorrhage was seen in 26/36 (72.2%) patients. Patients having a MRI between 4-6 weeks of the biopsy had hemorrhage in 8/14 (57.1%) cases. After 6 weeks, hemorrhage was less common but still present in 24/46 (52%) patients. There were five patients who had prostate MRI prior to biopsy and served as a control group. There was no significant correlation between the length of time beyond 6 weeks and the likelihood of having prostate hemorrhage on MRI. The overall sensitivity and specificity of MRI for predicting extracapsular extension (ECE) were 78.6% and 89%, respectively. However, if the analysis was limited to patients with MRI within 6 weeks from the time of biopsy, the sensitivity and specificity were similar: 80% and 90%, respectively. For patients with MRI obtained after 6 weeks, the sensitivity and specificity were 76.9% and 87.9%.
CONCLUSIONS: Prostate hemorrhage is seen in the majority of cases within 6 weeks of biopsy and can be seen in nearly half the patients even beyond 6 weeks. However, hemorrhage within 6 weeks of a biopsy does not interfere with assessment for ECE.

Entities:  

Mesh:

Year:  2015        PMID: 25891332

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  4 in total

1.  Time point-independent tumor positivity of 68Ga-PSMA-PET/CT pre- and post-biopsy in high-risk prostate cancer.

Authors:  Sijuan Zou; Shuang Song; Jianyuan Zhou; Bo Yu; Dong Kuang; Zhihua Wang; Xiaohua Zhu
Journal:  Ann Nucl Med       Date:  2022-04-01       Impact factor: 2.258

2.  Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project.

Authors:  M J Scheltema; K J Tay; A W Postema; D M de Bruin; J Feller; J J Futterer; A K George; R T Gupta; F Kahmann; C Kastner; M P Laguna; S Natarajan; S Rais-Bahrami; A R Rastinehad; T M de Reijke; G Salomon; N Stone; R van Velthoven; R Villani; A Villers; J Walz; T J Polascik; J J M C H de la Rosette
Journal:  World J Urol       Date:  2016-09-16       Impact factor: 4.226

3.  Multiparametric MRI reporting using Prostate Imaging Reporting and Data System version 2.0 (PI-RADSv2) retains clinical efficacy in a predominantly post-biopsy patient population.

Authors:  Edwin Jonathan Aslim; Yan Mee Law; Puay Hoon Tan; John Carson Allen; Lionel Tim-Ee Cheng; Viswanath Anand Chidambaram; Li Yan Khor; Benjamin Yongcheng Tan; Ernest Wencong Eu; Christopher Wai Sam Cheng; John Shyi Peng Yuen; Henry Sun Sien Ho; Lui Shiong Lee
Journal:  Asian J Urol       Date:  2018-06-01

4.  Incidental findings on multiparametric MRI performed for evaluation of prostate cancer.

Authors:  Rachael L Sherrer; Win Shun Lai; John V Thomas; Jeffrey W Nix; Soroush Rais-Bahrami
Journal:  Abdom Radiol (NY)       Date:  2018-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.